1993
DOI: 10.1073/pnas.90.23.11054
|View full text |Cite
|
Sign up to set email alerts
|

Expression and functional significance of an additional ligand for CTLA-4.

Abstract: Effective T-cell activation requires antigen/major histocompatibility complex engagement by the

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
150
2
1

Year Published

1994
1994
2013
2013

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 226 publications
(157 citation statements)
references
References 33 publications
4
150
2
1
Order By: Relevance
“…In addition, full activation of these cells requires the binding of costimulatory molecules expressed on one cell to costimulatory molecules expressed on the other (3,4). One such costimulatory molecule is CD86 (B7-2), which is expressed at a low level on a resting B cell (5,6), but is up-regulated following the stimulation of BCR (7,8), CD40 (9,10), MHC class II (11), LPS receptor (5,7,12,13), IL-4R (14,15), and/or ␤ 2 -adrenergic receptor (␤ 2 AR) (16,17). CD86 binds to the costimulatory molecule CD28 on the Th cell to increase the expression of the costimulatory molecule CD40 ligand (CD40L) on the Th cell and also to increase the level of cytokine produced by the Th cell (13,15,18).…”
Section: Selective Regulation Of Mature Igg1 Transcription By Cd86mentioning
confidence: 99%
“…In addition, full activation of these cells requires the binding of costimulatory molecules expressed on one cell to costimulatory molecules expressed on the other (3,4). One such costimulatory molecule is CD86 (B7-2), which is expressed at a low level on a resting B cell (5,6), but is up-regulated following the stimulation of BCR (7,8), CD40 (9,10), MHC class II (11), LPS receptor (5,7,12,13), IL-4R (14,15), and/or ␤ 2 -adrenergic receptor (␤ 2 AR) (16,17). CD86 binds to the costimulatory molecule CD28 on the Th cell to increase the expression of the costimulatory molecule CD40 ligand (CD40L) on the Th cell and also to increase the level of cytokine produced by the Th cell (13,15,18).…”
Section: Selective Regulation Of Mature Igg1 Transcription By Cd86mentioning
confidence: 99%
“…Opposite expression patterns of these costimulatory molecules were observed following L-PAM therapy of MOPC-315 tumor bearers (15). Specifically, B7-1 was up-regulated at the tumor site within 24 h after L-PAM treatment (15), whereas B7-2 was up-regulated after 48 h (11), which is similar to the time of up-regulation of B7-2 expression on APC exposed to the other stimuli (12)(13)(14). In light of these observations, we considered the possibility that in contrast to B7-2, which is up-regulated indirectly by L-PAM (i.e., L-PAM induces TNF-␣ production (16) that in turn leads to up-regulation of B7-2 surface expression; Ref.…”
Section: Mechanism Of Melphalanmentioning
confidence: 73%
“…Numerous investigators observed that B7-2 expression was upregulated earlier than B7-1 following stimulation of APCs with a variety of different stimuli including cytokines (e.g., GM-CSF), anti-CD40, or surface Ig ligation (12)(13)(14). Opposite expression patterns of these costimulatory molecules were observed following L-PAM therapy of MOPC-315 tumor bearers (15).…”
Section: Mechanism Of Melphalanmentioning
confidence: 99%
“…It is reported that both B7-1 and B7-2 are the ligands for CTLA4 and expressed on cell surface as membrane antigens [8][9][10][11]. CTLA4Ig binds these molecules with very high affinity [1].…”
Section: Ctla4ig From Transfected Mm1 Cells Binds Effectively To B7 Mmentioning
confidence: 99%
“…B7 molecules are expressed on a variety of cell types, including dentritic cells, B cells, T-cells and macrophages [8][9][10][11]. CTLA4Ig, a soluble form of CTLA4, could block B7 and CD28/CTLA4 pathway and results in the inhibitation of Tcell activation and autoimmune response [12][13][14][15][16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%